A 58-year-old male with 25 pack-year smoking and controlled HTN presents for primary prevention. LDL-C 142 mg/dL, no ASCVD, 10-year risk 12%. Best lip...

Question

A 58-year-old male with 25 pack-year smoking and controlled HTN presents for primary prevention. LDL-C 142 mg/dL, no ASCVD, 10-year risk 12%. Best lipid therapy?

Accepted Answer

Moderate-intensity statin therapy

Answer

No statin; lifestyle only

Answer

Ezetimibe monotherapy

Answer

High-intensity statin therapy

Answer

PCSK9 inhibitor monotherapy

us-abfm MCQ (SBA): Primary prevention dyslipidaemia

A 58-year-old male with 25 pack-year smoking and controlled HTN presents for primary prevention. LDL-C 142 mg/dL, no ASCVD, 10-year risk 12%. Best lipid therapy?